Kurt Van Gunst

Director Of Flow Cytometry at Ozette Technologies

Kurt Van Gunst has worked in the scientific field since 1997. Theirfirst position was a Scientific Voluntary Intern at The Scripps Research Institute, followed by a Research Assistant III and then a Flow Cytometry Operator. In 2005, they moved to Cytori Therapeutics as a Research Associate III - Flow Cytometry Operator. In 2007, they began working at BD Biosciences as a Research Reagent Sales Specialist. From 2008 to 2015, they were a Flow Cytometry Specialist IV at La Jolla Institute for Allergy and Immunology. In 2015, they moved to Human Longevity, Inc. as a Flow Cytometry Specialist. From 2017 to 2020, they worked at Juno Therapeutics, Inc. as a Sr. Associate Scientist - Cellular Phenotype and Sr. Associate Scientist - Product Sciences. In 2020, they began working at Bristol Myers Squibb as a Principal Scientist, Head of Custom & Process Analytics. Currently, they are a Principal Research Scientist at Ozette Technologies, where they are working to unlock the immune system to prevent disease using novel computational methods and machine learning.

Kurt Van Gunst obtained a Bachelor of Science in Animal Physiology and Neuroscience from UC San Diego between 1995 and 1999. In April 2015, they received a Certified Cytometrist, C.Cy. certification from the International Society for Analytical Cytology (ISAC).

Location

Seattle, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Ozette Technologies

1 followers

Ozette is a life sciences data startup company that develops an artificial intelligence-enabled immune monitoring platform.


Industries

Employees

11-50

Links